These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18581650)

  • 1. [Point mutations behind familial dysalbuminemic hyperthyroxinemia].
    Nørby S
    Ugeskr Laeger; 2008 Jun; 170(25):2259; author reply 2260. PubMed ID: 18581650
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial dysalbuminemic hyperthyroxinemia].
    Hartling UB; Nielsen TL; Brøns M
    Ugeskr Laeger; 2005 Jan; 167(3):300-1. PubMed ID: 15704803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial dysalbuminemic hyperthyroxinemia. A diagnostic pitfall].
    Jensen IW; Stentoft J; Toft E; Faber J
    Ugeskr Laeger; 1988 Sep; 150(37):2178-80. PubMed ID: 3206581
    [No Abstract]   [Full Text] [Related]  

  • 4. Linkage of familial dysalbuminemic hyperthyroxinemia to the albumin gene in a large Amish kindred.
    Weiss RE; Sunthornthepvarakul T; Angkeow P; Marcus-Bagley D; Cox N; Alper CA; Refetoff S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):116-21. PubMed ID: 7829599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine.
    Pannain S; Feldman M; Eiholzer U; Weiss RE; Scherberg NH; Refetoff S
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2786-92. PubMed ID: 10946882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation in the albumin gene in a Chinese patient with familial dysalbuminemic hyperthyroxinemia.
    Tang KT; Yang HJ; Choo KB; Lin HD; Fang SL; Braverman LE
    Eur J Endocrinol; 1999 Oct; 141(4):374-8. PubMed ID: 10526251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated thyroxine and free thyroxine in euthyroid patients: familial dysalbuminemic hyperthyroxinemia.
    Haas S
    S D J Med; 1990 Mar; 43(3):5-7. PubMed ID: 2109350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial dysalbuminemic hyperthyroxinemia in long-term amiodarone treated patients].
    Sternad H; Eber B; Langsteger W; Prohaska R; Költringer P; Wawschinek O; Klein W; Eber O
    Acta Med Austriaca; 1994; 21(1):8-10. PubMed ID: 8017165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families.
    Sunthornthepvarakul T; Angkeow P; Weiss RE; Hayashi Y; Refetoff S
    Biochem Biophys Res Commun; 1994 Jul; 202(2):781-7. PubMed ID: 8048949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease.
    Young RA; Stoffer SS; Braverman LE
    Am J Med; 1987 Feb; 82(2):221-3. PubMed ID: 3812513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial dysalbuminemic hyperthyroxinemia.
    Jensen IW; Faber J
    Acta Med Scand; 1987; 221(5):469-73. PubMed ID: 3111180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia.
    Rushbrook JI; Becker E; Schussler GC; Divino CM
    J Clin Endocrinol Metab; 1995 Feb; 80(2):461-7. PubMed ID: 7852505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.
    Wada N; Chiba H; Shimizu C; Kijima H; Kubo M; Koike T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3246-50. PubMed ID: 9329347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum thyroiditis and familial dysalbuminemic hyperthyroxinemia.
    Langsteger W; Semlitsch G; Költringer P; Meister E; Eber O
    J Clin Endocrinol Metab; 1994 Jan; 78(1):58-62. PubMed ID: 8288714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype.
    Petersen CE; Ha CE; Harohalli K; Park DS; Feix JB; Isozaki O; Bhagavan NV
    Clin Chem; 1999 Aug; 45(8 Pt 1):1248-54. PubMed ID: 10430791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics.
    Petersen CE; Ha CE; Harohalli K; Park DS; Bhagavan NV
    Chem Biol Interact; 2000 Feb; 124(3):161-72. PubMed ID: 10728776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
    Petersen CE; Ha CE; Jameson DM; Bhagavan NV
    J Biol Chem; 1996 Aug; 271(32):19110-7. PubMed ID: 8702585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing.
    Arevalo G
    Clin Chem; 1991 Aug; 37(8):1430-1. PubMed ID: 1868606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.
    Petersen CE; Scottolini AG; Cody LR; Mandel M; Reimer N; Bhagavan NV
    J Med Genet; 1994 May; 31(5):355-9. PubMed ID: 8064810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a human serum albumin variant with high affinity for thyroxine.
    Petersen CE; Ha CE; Mandel M; Bhagavan NV
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1121-9. PubMed ID: 7575519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.